RAÚL
POZA DE CELIS
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaHospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study
World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466